HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Congestive cardiomyopathy]

AbstractIdiopathic congestive cardiomyopathy, which is often the result of a silent viral myocarditis, will occur in about 400 patients per year in Belgium. However, a comparable clinical and paraclinical picture, characterized by dilatation of the cardiac chambers and diffuse and profound hypocontractility of the myocardium, can be the common consequence of a large number of cardiac diseases. In front of a clinical presentation of heart failure, the physician will aim to identify the global myocardial insult and to rule out etiologies which, corrected, do not necessarily produce irreversible myocardial damage. This differential diagnosis will be based on medical history, physical examination, echocardiography and coronary angiography. Prognosis of congestive cardiomyopathy, although generally poor, can be greatly improved by a rational pharmacological therapy as well as new interventions (implantable defibrillator, cardiac transplantation) whose correct indications rely on technological advances and a better knowledge of the natural history of the disease.
AuthorsJ L Vandenbossche (Affiliation: Clinique cardiologique, Hôpital Universitaire Saint-Pierre, Bruxelles.)
JournalRevue médicale de Bruxelles (Rev Med Brux) 1995 Jul-Aug Vol. 16 Issue 4 Pg. 187-9 ISSN: 0035-3639 [Print] BELGIUM
Vernacular TitleLa cardiomyopathie congestive.
PMID7481220 (Publication Type: English Abstract, Journal Article)
Topics
  • Cardiomyopathy, Alcoholic (complications)
  • Cardiomyopathy, Dilated (diagnosis, etiology, therapy)
  • Combined Modality Therapy
  • Echocardiography
  • Electrocardiography
  • Humans
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD